Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@mtheory11bio Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1555606459.png) @mtheory11bio Chris Carper

Chris Carper posts on X about $bhvn, $vyne, $tecx, $azn the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::1555606459/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1555606459/c:line/m:interactions.svg)

- X Week XXXXX +21%
- X Month XXXXXX -XX%
- X Months XXXXXXX +23%
- X Year XXXXXXX -XX%

### Mentions: X [#](/creator/twitter::1555606459/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1555606459/c:line/m:posts_active.svg)

- X Week X +100%
- X Month XX -XX%
- X Months XX +35%
- X Year XXX -XX%

### Followers: XXXXX [#](/creator/twitter::1555606459/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1555606459/c:line/m:followers.svg)

- X Week XXXXX +0.19%
- X Month XXXXX +4.90%
- X Months XXXXX +11%
- X Year XXXXX +13%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::1555606459/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1555606459/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::1555606459/influence)
---

**Social category influence**
[stocks](/list/stocks)  XXXX% [currencies](/list/currencies)  XXXX%

**Social topic influence**
[$bhvn](/topic/$bhvn) 3.85%, [$vyne](/topic/$vyne) 3.85%, [$tecx](/topic/$tecx) 3.85%, [$azn](/topic/$azn) XXXX%

**Top accounts mentioned or mentioned by**
[@aaronrosenblum5](/creator/undefined) [@persimmonti](/creator/undefined) [@stephanklingel1](/creator/undefined) [@mufaso7](/creator/undefined) [@bioluck80](/creator/undefined) [@biopharmiq](/creator/undefined) [@plainyogurt21](/creator/undefined) [@bbgreatmoments](/creator/undefined) [@sharkbiotech](/creator/undefined) [@golfdigest](/creator/undefined) [@jonnyfunguy](/creator/undefined) [@feldtinvesting](/creator/undefined) [@pharmdca](/creator/undefined) [@jeffbrown998](/creator/undefined) [@stocksdd](/creator/undefined) [@meadowcapital](/creator/undefined) [@johnadams98474](/creator/undefined) [@a_may_md](/creator/undefined) [@ilzizzo](/creator/undefined) [@ej23ny](/creator/undefined)

**Top assets mentioned**
[Biohaven Pharmaceutical Holding Company Ltd. (BHVN)](/topic/$bhvn) [AstraZeneca PLC (AZN)](/topic/$azn)
### Top Social Posts [#](/creator/twitter::1555606459/posts)
---
Top posts by engagements in the last XX hours

"$BHVN is interesting because would the FDA say haha j/k in a CRL if troriluzole hit X pre-specified primary and secondary endpoints in the RWE study that the FDA helped design"  
[X Link](https://x.com/mtheory11bio/status/1973743867393699948) [@mtheory11bio](/creator/x/mtheory11bio) 2025-10-02T13:36Z 5246 followers, 9842 engagements


"Me patiently waiting for the $VYNE vitiligo readout"  
[X Link](https://x.com/mtheory11bio/status/1946310905718812764) [@mtheory11bio](/creator/x/mtheory11bio) 2025-07-18T20:47Z 5247 followers, 5191 engagements


"Like the setup for $TECX as expectations are low heading into the HFrEF + $AZN Re-PHIRE readouts. The primary endpoint for Re-PHIRE is change in PVR vs pbo but w/ the inclusion of ipcPH patients (which have normal PVR) secondary endpoints and subgroups should be more important"  
[X Link](https://x.com/mtheory11bio/status/1978474430461366607) [@mtheory11bio](/creator/x/mtheory11bio) 2025-10-15T14:53Z 5247 followers, 2854 engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@mtheory11bio Avatar @mtheory11bio Chris Carper

Chris Carper posts on X about $bhvn, $vyne, $tecx, $azn the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

  • X Week XXXXX +21%
  • X Month XXXXXX -XX%
  • X Months XXXXXXX +23%
  • X Year XXXXXXX -XX%

Mentions: X #

Mentions Line Chart

  • X Week X +100%
  • X Month XX -XX%
  • X Months XX +35%
  • X Year XXX -XX%

Followers: XXXXX #

Followers Line Chart

  • X Week XXXXX +0.19%
  • X Month XXXXX +4.90%
  • X Months XXXXX +11%
  • X Year XXXXX +13%

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence #


Social category influence stocks XXXX% currencies XXXX%

Social topic influence $bhvn 3.85%, $vyne 3.85%, $tecx 3.85%, $azn XXXX%

Top accounts mentioned or mentioned by @aaronrosenblum5 @persimmonti @stephanklingel1 @mufaso7 @bioluck80 @biopharmiq @plainyogurt21 @bbgreatmoments @sharkbiotech @golfdigest @jonnyfunguy @feldtinvesting @pharmdca @jeffbrown998 @stocksdd @meadowcapital @johnadams98474 @a_may_md @ilzizzo @ej23ny

Top assets mentioned Biohaven Pharmaceutical Holding Company Ltd. (BHVN) AstraZeneca PLC (AZN)

Top Social Posts #


Top posts by engagements in the last XX hours

"$BHVN is interesting because would the FDA say haha j/k in a CRL if troriluzole hit X pre-specified primary and secondary endpoints in the RWE study that the FDA helped design"
X Link @mtheory11bio 2025-10-02T13:36Z 5246 followers, 9842 engagements

"Me patiently waiting for the $VYNE vitiligo readout"
X Link @mtheory11bio 2025-07-18T20:47Z 5247 followers, 5191 engagements

"Like the setup for $TECX as expectations are low heading into the HFrEF + $AZN Re-PHIRE readouts. The primary endpoint for Re-PHIRE is change in PVR vs pbo but w/ the inclusion of ipcPH patients (which have normal PVR) secondary endpoints and subgroups should be more important"
X Link @mtheory11bio 2025-10-15T14:53Z 5247 followers, 2854 engagements

creator/x::mtheory11bio
/creator/x::mtheory11bio